Liquid Oxygen Devices Market (2026 - 2033)

Liquid Oxygen Devices Market Summary

The global liquid oxygen devices market size was valued at USD 1.8 billion in 2025 and is projected to grow from USD 1.9 billion in 2026 to USD 2.9 billion by 2033, growing at a CAGR of 5.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 44.0% in 2025. Liquid oxygen is a crucial medical resource used for various medical applications, especially in respiratory care and critical care settings.

The rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and acute respiratory distress syndrome (ARDS) leads to a consistent need for oxygen therapy and support, thereby driving the market.

Liquid oxygen is a crucial medical resource used for various medical applications, especially in respiratory care and critical care settings. The rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and acute respiratory distress syndrome (ARDS) leads to a consistent need for oxygen therapy and support, thereby driving the market.

Technological advancements have led to the development of more efficient and user-friendly oxygen concentrators. One of the key advancements is making liquid oxygen concentrators more portable and lightweight. Also, newer models are designed to be easily carried by patients, allowing them to maintain an active lifestyle while receiving oxygen therapy. In addition, advancements in molecular sieve technology, which is used to extract oxygen from the air, have led to more efficient and effective oxygen concentration. This allows patients to receive higher levels of oxygen while still using compact devices. Furthermore, the development of compact and lightweight liquid oxygen concentrators allows patients to carry their oxygen therapy devices with them wherever they go. This level of portability is especially important for maintaining patient mobility and independence. This is expected to drive the market over the forecast period.

The outbreak of the COVID-19 pandemic accelerated the demand for liquid oxygen, thereby impelling the market growth. As hospitals faced capacity challenges, there was a growing preference for treating less severe cases at home to minimize the risk of exposure. This drove the demand for liquid oxygen therapy devices that could be used safely and effectively outside of healthcare facilities. Moreover, various initiatives undertaken to boost the production of liquid oxygen positively impacted the market. For instance, in August 2021, the Delhi Government notified and approved the Medical Oxygen Production Promotion Policy of Delhi, 2021 to ensure there is no shortage of medical oxygen in the wake of Covid 19.  This policy aimed to ensure time-bound fulfillment of the targets such as setting up liquid oxygen (LOX) manufacturing facilities, non-captive & captive oxygen generation plants, and others, thereby boosting the market.

Market Dynamics

The market is expected to experience significant growth over the forecast period, owing to factors such as the prevalence of chronic respiratory diseases, the growing number of patients with ongoing Long-Term Oxygen Therapy (LTOT), facility expansions initiated by multiple care providers, and increasing use in specialized drug production processes. The rising demand for portable and at-home oxygen services and the development of innovative oxygen concentrators also contribute to the growth. The advanced home healthcare expansion and telemedicine integrations present lucrative opportunities for this market. However, stringent regulatory frameworks and severe safety hazards may hinder the pace of growth. Key players have been focusing on the inclusion of technology features in a variety of products, such as integrated Bluetooth, IoT sensors, and telehealth modules.

Analyst Perspective

The liquid oxygen devices industry is witnessing stable growth driven by increasing incidence of respiratory disease, growing elderly population and increasing inclination toward home healthcare. The penetration of liquid oxygen devices is restricted in developing markets owing to high infrastructure and storage costs. However, the industry offers lucrative opportunities to manufacturers who are concentrating on the development of portable and energy-efficient liquid oxygen devices. Investment in compact oxygen concentrator technology and an increase in healthcare availability are expected to influence the future growth of the industry.

End-use Insights

Based on end-use, the homecare segment accounted for the largest revenue share in 2025. There has been a growing trend toward providing healthcare services at home, driven by patient preference, cost-effectiveness, and advancements in medical technology. Liquid oxygen devices enable patients to receive oxygen therapy in the comfort of their homes, reducing the need for frequent hospital visits. Liquid oxygen devices, especially portable models, allow patients to move around more freely while still receiving their prescribed oxygen therapy. This increased mobility enhances patients' ability to engage in daily activities and maintain a more active lifestyle. Also, the pandemic emphasized the importance of home-based care to reduce the risk of exposure in healthcare settings. This accelerated the adoption of homecare solutions, including liquid oxygen devices, for patients requiring oxygen therapy.

The outpatient facilities segment is expected to grow at the fastest CAGR over the forecast period. Liquid oxygen devices play a crucial role in delivering oxygen therapy to patients with conditions such as COPD, asthma, and interstitial lung diseases. Integrating liquid oxygen devices into outpatient settings allows for a seamless transition of care for patients who require ongoing oxygen therapy. This continuum of care supports patients' needs from acute care to recovery and long-term management. Also, patients can receive oxygen therapy in outpatient facilities without the need for hospitalization. This convenience is especially beneficial for individuals who do not require intensive inpatient care but still need oxygen support. Furthermore, outpatient facilities equipped with liquid oxygen devices can help prevent unnecessary hospital admissions for patients who only need oxygen therapy. This reduces the burden on hospitals and ensures that beds are available for more critical cases.

Regional Insights

North America accounted for the largest market share of more than 44.0% in 2025 and is anticipated to grow at the fastest CAGR over the forecast period. The key factors responsible for this are the presence of an aging population, the increasing prevalence of respiratory conditions, and advancements in medical technology. Technological innovation has driven the development of more efficient, portable, and user-friendly liquid oxygen concentrators. These advancements have contributed to higher adoption rates and increased patient satisfaction.

Many patients in North America prefer home-based care over hospital stays. Liquid oxygen devices have gained popularity as they enable patients to receive oxygen therapy in the comfort of their homes, supporting the trend of home-based healthcare. In addition, well-established regulatory frameworks for medical devices, ensuring safety and quality standards, foster trust among patients and healthcare providers in adopting liquid oxygen devices, thereby driving the market.

Asia Pacific Liquid Oxygen Devices Market

The liquid oxygen devices market in Asia Pacific is expected to witness significant growth over the forecast period. The region is home to a range of manufacturers and suppliers of medical devices, which contribute to market competition and potentially drive innovation. This factor is expected to fuel the regional industry's growth. According to the review article "Respiratory Diseases in India and the Roles of Government and Public Health Authorities for Its Control," published in the Indian Journal of Respiratory Care in January 2026, India is facing a severe respiratory health crisis. The country accounts for an estimated 34.3 million cases of Asthma and COPD combined.

Key Liquid Oxygen Devices Companies Insights

Competition among companies is expected to be intense in the global liquid oxygen devices market, primarily due to the presence of numerous players. In response to changing consumer trends, several companies are expanding their product portfolios to gain a competitive advantage.

Key Liquid Oxygen Devices Companies

The following key companies have been profiled for this study on the liquid oxygen devices market

• CAIRE

• CRYOFAB

• Philips

• Airliquide

• Inogen

Recent Developments

• In February 2026, a commercial-stage digital health organization, Profusa, entered in know-how agreement with Mayo Clinic. The collaboration aimed at advancing the clinical use of continuous oxygen monitoring technologies.

• In February 2026, Unitai, an international, hosted partnership among Brazil, Chile, France, Norway, and the the UK within the WHO and a global nonprofit, PATH, launched a four-year initiative, Innovations for Enhanced Access to Oxygen (INNOVATE)

• In September 2025, The Sapio Group, Groupe Bastide acquired UK respiratory care market participant Baywater Healthcare from the French group Bastide. This is expected to add significant strength to its portfolio.

Liquid Oxygen Devices Market Report Scope 

Liquid Oxygen Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global liquid oxygen devices market report based on end-use and region:

• End-use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospitals

  • Outpatient Facilities

  • Home Care

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • Italy

    • Spain

    • France

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • Thailand

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait